Patents by Inventor HANS HOLMEGAARD SORENSEN

HANS HOLMEGAARD SORENSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation
    Patent number: 8841252
    Abstract: The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: September 23, 2014
    Assignee: Novo Nordisk Health Care AG
    Inventors: Søren Bjørn, Hans Holmegaard Sørensen, Peter Langballe, Silke Møller Larsen, Kristen Ebbehøj, Birthe Lykkegaard Hansen
  • Pharmaceutical Formulation
    Publication number: 20100029569
    Abstract: The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.
    Type: Application
    Filed: October 8, 2009
    Publication date: February 4, 2010
    Applicant: Novo Nordisk Healthcare AG
    Inventors: Søren Bjørn, Hans Holmegaard Sørensen, Peter Langballe, Silke Møller Larsen, Kirsten Ebbehøj, Birthe Lykkegaard Hansen
  • Pharmaceutical formulation
    Publication number: 20030162711
    Abstract: The invention relates to pharmaceutical formulations comprising growth hormone, an amino acid selected from the group of Asp, Ile, Val, Leu or His, or a derivative of histidine, or a peptide comprising at least one basic amino acid and at least one acidic amino acid, and a non-ionic detergent, eg. polysorbate or poloxamer.
    Type: Application
    Filed: January 22, 2003
    Publication date: August 28, 2003
    Inventors: Soren Bjorn, Hans Holmegaard Sorensen, Peter Langballe, Silke Moller Larsen, Kirsten Ebbehoj, Birthe Lykkegaard Hansen
  • Freeze-dried preparation of human growth hormone
    Patent number: 6566329
    Abstract: A readily-soluble freeze-dried solid preparation of hGH with a minimal content of degradation products in terms of deamidation, dimers, polymers, and sulphoxide forms, obtainable by a method comprising a single lyophilization of an aqueous slurry of an amorphous hGH isoprecipitate, the slurry having a pH of from about 4.7 to 5.0 and being essentially free of buffer components other than acetate.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: May 20, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Giorgio Meyn, Hans Holmegaard Sørensen, Thorkild Christensen
  • PHARMACEUTICAL FORMULATION
    Publication number: 20020077461
    Abstract: The invention relates to pharmaceutical formulations comprising growth hormone, an amino acid selected from the group of Asp, Ile, Val, Leu or His, or a derivative of histidine, or a peptide comprising at least one basic amino acid and at least one acidic amino acid, and a non-ionic detergent, eg. polysorbate or poloxamer.
    Type: Application
    Filed: April 23, 1997
    Publication date: June 20, 2002
    Inventors: SOREN BJORN, HANS HOLMEGAARD SORENSEN, PETER LANGBALLE, SILKE MOLLER LARSEN, KIRSTEN EBBEHOJ, BIRTHE LYKKEGAARD HANSEN